Newborn With Conjugated Hyperbilirubinemia and a Liver Biopsy
A 6-week-old former 36-week infant presents with jaundice, pale stools, and a conjugated bilirubin of 6.8 mg/dL (direct fraction 70%). He was breastfed and gained weight poorly. Ultrasound shows a small gallbladder and no bile duct dilatation. A liver biopsy shows portal tract edema and fibrosis, ductular proliferation, and bile plugs within ductules, with a few multinucleated giant cells. The surgeon asks whether this is biliary atresia and whether a Kasai procedure is indicated.
1. How do you interpret the biopsy, and what are the mimics of biliary atresia on histology?
Read the worked answer
The biopsy shows a biliary obstructive pattern: portal edema, fibrosis, ductular proliferation, and bile plugs in ductules, with giant cell transformation. This is compatible with biliary atresia but is not specific.
Mimics with overlapping histology include:
- Neonatal hepatitis (idiopathic or infectious) - giant cells and inflammation, but ductular proliferation and fibrosis are usually less prominent.
- Alpha-1-antitrypsin deficiency - PAS-positive, diastase-resistant globules in periportal hepatocytes; check PAS-D staining and phenotype/genotype.
- Cystic fibrosis - focal biliary cirrhosis; sweat chloride or CFTR testing.
- Metabolic disorders (galactosemia, tyrosinemia, bile acid synthesis defects) - clinical and biochemical correlation.
- Total parenteral nutrition and drug injury.
- Paucity of interlobular bile ducts (Alagille, Zellweger) - the opposite pattern, with reduced duct-to-portal-tract ratio.
The decisive test is intraoperative cholangiography at the time of planned Kasai, plus careful histologic assessment of duct size and fibrosis. Biopsy alone cannot reliably separate biliary atresia from severe neonatal hepatitis in every case.
2. What features on biopsy would make you more confident in biliary atresia, and what would argue against it?
Read the worked answer
Features favoring biliary atresia:
- Ductular proliferation with neutrophilic inflammation around proliferating ductules.
- Bile plugs in ductules and canals of Hering.
- Portal fibrosis/edema with bridging fibrosis.
- Absence of interlobular bile ducts in some portal tracts (ductopenia) - a key finding when present.
- Giant cell transformation can occur in both, so it is not discriminating.
Features arguing against:
- Well-preserved interlobular bile ducts with prominent lobular inflammation and giant cells - favors neonatal hepatitis.
- Marked steatosis or specific inclusions/globules - points to metabolic disease.
- Duct paucity without proliferation - consider Alagille or other syndromic paucity.
- Minimal portal fibrosis with predominantly lobular disease.
Because sampling error is real, a needle biopsy may miss the diagnostic portal tract; a second opinion or repeat biopsy is sometimes needed. The pathologist should report the duct-to-portal-tract ratio, degree of fibrosis, and presence of bile plugs, and should state explicitly that the findings are "consistent with" rather than "diagnostic of" biliary atresia.
3. The infant undergoes Kasai at 7 weeks. What does the timing imply for prognosis, and what should the pathology report of the excised remnant include?
Read the worked answer
Timing matters: Kasai portoenterostomy performed before 60 days of age is associated with better native-liver survival; after roughly 90 days, outcomes decline substantially. At 7 weeks (49 days) this infant is within the favorable window, which supports proceeding.
The excised fibrous remnant should be examined for:
- Presence and size of residual bile ducts at the porta hepatis - ductules >150–200 µm are associated with better bile drainage, though the predictive value is debated.
- Degree of fibrosis and inflammation.
- Confirmation of the diagnosis (absence of a patent extrahepatic biliary tree, fibrous obliteration).
- Exclusion of other disease (e.g., cystic changes, inspissated bile).
Postoperative prognosis depends on establishment of bile flow, clearance of jaundice, and prevention of cholangitis. Even with a successful Kasai, many children eventually require transplantation, so the family should be counseled that Kasai is a bridge or a long-term option, not a guaranteed cure. The pathologist should communicate the duct size and fibrosis grade to the surgical team, since these inform expectations.